Fetal and Neonatal Alloimmune ThrombocytopeniaSymptoms, Doctors, Treatments, Advances & More
Fetal and Neonatal Alloimmune Thrombocytopenia Overview
Learn About Fetal and Neonatal Alloimmune Thrombocytopenia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Jens Kragh-Kjeldsen practices practicing medicine in Lund, Sweden. Mr. Kragh-Kjeldsen is rated as an Elite expert by MediFind in the treatment of Fetal and Neonatal Alloimmune Thrombocytopenia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fetal and Neonatal Alloimmune Thrombocytopenia, Thrombocytopenia, ABO Incompatibility, and Hemolytic Disease of the Newborn.
Heidi Tiller practices practicing medicine in Tromso, Norway. Ms. Tiller is rated as an Elite expert by MediFind in the treatment of Fetal and Neonatal Alloimmune Thrombocytopenia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Fetal and Neonatal Alloimmune Thrombocytopenia, Thrombocytopenia, and ABO Incompatibility.
Cecile Kaplan practices practicing medicine in Paris, France. Ms. Kaplan is rated as an Elite expert by MediFind in the treatment of Fetal and Neonatal Alloimmune Thrombocytopenia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Fetal and Neonatal Alloimmune Thrombocytopenia and Thrombocytopenia.
Summary: The purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Summary: The purpose of this study is to evaluate the effectiveness of nipocalimab compared with placebo in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).